Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 909

  • Filters activated: Cancer. Clear all to show 6131 items.
1.
2.

The cubane paradigm in bioactive molecule discovery: further scope, limitations and the cyclooctatetraene complement.

Houston SD, Fahrenhorst-Jones T, Xing H, Chalmers BA, Sykes ML, Stok JE, Farfan Soto C, Burns JM, Bernhardt PV, De Voss JJ, Boyle GM, Smith MT, Tsanaktsidis J, Savage GP, Avery VM, Williams CM.

Org Biomol Chem. 2019 Jul 17;17(28):6790-6798. doi: 10.1039/c9ob01238a.

PMID:
31241113
3.

Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain: The Alliance A221304 Randomized Clinical Trial.

Sio TT, Le-Rademacher JG, Leenstra JL, Loprinzi CL, Rine G, Curtis A, Singh AK, Martenson JA Jr, Novotny PJ, Tan AD, Qin R, Ko SJ, Reiter PL, Miller RC.

JAMA. 2019 Apr 16;321(15):1481-1490. doi: 10.1001/jama.2019.3504.

PMID:
30990550
4.

The Search for an Effective Therapy and Pain Relief for Oral Mucositis.

Elad S, Yarom N.

JAMA. 2019 Apr 16;321(15):1459-1461. doi: 10.1001/jama.2019.3269. No abstract available.

PMID:
30990535
5.

Successful mast-cell-targeted treatment of chronic dyspareunia, vaginitis, and dysfunctional uterine bleeding.

Afrin LB, Dempsey TT, Rosenthal LS, Dorff SR.

J Obstet Gynaecol. 2019 Jul;39(5):664-669. doi: 10.1080/01443615.2018.1550475. Epub 2019 Apr 9.

PMID:
30964355
6.

Predicting Outcomes in Patients With Diffuse Large B-Cell Lymphoma Treated With Standard of Care.

Galaznik A, Reich C, Klebanov G, Khoma Y, Allakhverdiiev E, Hather G, Shou Y.

Cancer Inform. 2019 Mar 15;18:1176935119835538. doi: 10.1177/1176935119835538. eCollection 2019.

7.

Etoposide phosphate for pediatric orthopedic malignancies after intravenous etoposide hypersensitivity.

Brooks JP, Azmy V, Thompson A, Luon D, Prozora SD, Price C, Hsu FI.

J Oncol Pharm Pract. 2019 Mar 18:1078155219836478. doi: 10.1177/1078155219836478. [Epub ahead of print]

PMID:
30885040
8.

Evaluation of Miracle Mouthwash plus Hydrocortisone Versus Prednisolone Mouth Rinses as Prophylaxis for Everolimus-Associated Stomatitis: A Randomized Phase II Study.

Jones VE, McIntyre KJ, Paul D, Wilks ST, Ondreyco SM, Sedlacek S, Melnyk A, Oommen SP, Wang Y, Peck SR, O'Shaughnessy JA.

Oncologist. 2019 Mar 4. pii: theoncologist.2018-0340. doi: 10.1634/theoncologist.2018-0340. [Epub ahead of print]

PMID:
30833486
9.

Involvement of histamine H1 and H2 receptor inverse agonists in receptor's crossregulation.

Díaz Nebreda A, Zappia CD, Rodríguez González A, Sahores A, Sosa M, Burghi V, Monczor F, Davio C, Fernández N, Shayo C.

Eur J Pharmacol. 2019 Mar 15;847:42-52. doi: 10.1016/j.ejphar.2019.01.026. Epub 2019 Jan 24.

PMID:
30685431
10.

Suppression of IFN-γ Production in Murine Splenocytes by Histamine Receptor Antagonists.

Kamei M, Otani Y, Hayashi H, Nakamura T, Yanai K, Furuta K, Tanaka S.

Int J Mol Sci. 2018 Dec 17;19(12). pii: E4083. doi: 10.3390/ijms19124083.

11.

Piperlongumine, a piper alkaloid targets Ras/PI3K/Akt/mTOR signaling axis to inhibit tumor cell growth and proliferation in DMH/DSS induced experimental colon cancer.

Kumar S, Agnihotri N.

Biomed Pharmacother. 2019 Jan;109:1462-1477. doi: 10.1016/j.biopha.2018.10.182. Epub 2018 Nov 13.

12.

Endogenous Nitric Oxide Inhibits, Whereas Awakening Stimuli Increase, the Activity of a Subset of Orexin Neurons.

Yamakawa T, Kurauchi Y, Hisatsune A, Seki T, Katsuki H.

Biol Pharm Bull. 2018;41(12):1859-1865. doi: 10.1248/bpb.b18-00633.

13.

Acute phenibut withdrawal: A comprehensive literature review and illustrative case report.

Hardman MI, Sprung J, Weingarten TN.

Bosn J Basic Med Sci. 2019 May 20;19(2):125-129. doi: 10.17305/bjbms.2018.4008. Review.

14.

Brentuximab Vedotin Infusion Reaction Management: A Case Study.

Comer H, Cardwell K.

J Adv Pract Oncol. 2017 Sep-Oct;8(6):626-629. Epub 2017 Sep 1. Review.

15.

Diphenhydramine.

Sicari V, Zabbo CP.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 Apr 28.

16.

Rapid infusion rituximab is well tolerated in patients with primary CNS lymphoma.

Modelevsky L, Tizon R, Reiss SN, Smith M, Garonce R, Kaley T.

CNS Oncol. 2018 Jul 1;7(3):CNS19. doi: 10.2217/cns-2018-0001. Epub 2018 Sep 17.

17.

The long duration of action of the second generation antihistamine bilastine coincides with its long residence time at the histamine H1 receptor.

Bosma R, van den Bor J, Vischer HF, Labeaga L, Leurs R.

Eur J Pharmacol. 2018 Nov 5;838:107-111. doi: 10.1016/j.ejphar.2018.09.011. Epub 2018 Sep 7.

18.

Identification of Primary Natural Killer Cell Modulators by Chemical Library Screening with a Luciferase-Based Functional Assay.

Hayek S, Bekaddour N, Besson L, Alves de Sousa R, Pietrancosta N, Viel S, Smith N, Jacob Y, Nisole S, Mandal R, Wishart DS, Walzer T, Herbeuval JP, Vidalain PO.

SLAS Discov. 2019 Jan;24(1):25-37. doi: 10.1177/2472555218797078. Epub 2018 Sep 5.

PMID:
30184441
19.

The feasibility of dexamethasone omission in weekly paclitaxel treatment for breast cancer patients.

de Castro Baccarin AL, Irene MN, de Iracema Gomes Cubero D, Luz AS, Castro SN, Sordi R, Móz LES, Del Giglio A.

Support Care Cancer. 2019 Mar;27(3):927-931. doi: 10.1007/s00520-018-4381-0. Epub 2018 Aug 1.

PMID:
30069696
20.

[Machine Learning-based Prediction of Seizure-inducing Action as an Adverse Drug Effect].

Gao M, Sato M, Ikegaya Y.

Yakugaku Zasshi. 2018;138(6):809-813. doi: 10.1248/yakushi.17-00213-1. Review. Japanese.

Supplemental Content

Loading ...
Support Center